Onderneming Context Therapeutics Inc.
Aandelen
US21077P1084
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 5
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Felix Kim
FOU | Founder | - | 01-04-15 |
Martin Lehr
FOU | Founder | 40 | 01-04-15 |
Director of Finance/CFO | 46 | 01-11-21 | |
Priya Marreddy
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Christopher Beck
COO | Chief Operating Officer | - | 05-01-22 |
Alex Levit
LAW | General Counsel | 45 | 01-04-21 |
Evan G. Dick
PRN | Corporate Officer/Principal | 72 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Richard Berman
CHM | Chairman | 81 | 01-03-21 |
Jennifer Stacey
BRD | Director/Board Member | 59 | 01-03-21 |
Philip Kantoff
BRD | Director/Board Member | 69 | 01-12-18 |
Linda West
BRD | Director/Board Member | 64 | 01-03-21 |
Martin Lehr
FOU | Founder | 40 | 01-04-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 74 998 312 | 72 912 907 ( 97,22 %) | 0 | 97,22 % |
Bedrijfsgegevens
Context Therapeutics, Inc.
2001 Market Street Unit 15
19103, Philadelphia
+
http://www.contexttherapeutics.com![Adres Context Therapeutics Inc.](https://cdn.zonebourse.com/static/address/125228563.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,80% | 53,67 mld. | |
+34,58% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |